New COVID-19 shock: Scientists reveal what vaccines are really capable of As new COVID-19 variants continue to emerge, ...

Pfizer reported a dip in profits Tuesday, driven partly by lower sales of Covid-19 therapeutic drug Paxlovid, as it maintained a 2025 forecast that does not include potential tariff effects.

If you don't have the REAL ID by the deadline, passengers over 18 won't be able to fly domestically, as well as enter some ...

Pfizer said it still expects adjusted 2025 profit of $2.80 a share to $3 a share, while analysts expect full-year earnings of $2.94 a share. Pfizer also projected 2025 revenue of $61 billion to $64 ...

Cyprus recorded a drop in road deaths for the second year in a row, data released by Eurostat on Tuesday showed. A total of ...

Oceaneering shares are down 31.2% YTD, but their 59% ROV market share, diverse growth, and 2025 outlook make them a strong ...

Imagine this: you pull your kids out of school for a year, stash your stuff in storage, rent out your house, put your ...